RGEN

Repligen Corporation, headquartered in Waltham, Massachusetts, is a leading provider of bioprocessing technologies and systems that enhance the development and manufacturing of biologic drugs. The company's innovative solutions, which span from upstream to downstream processes, are utilized by biopharmaceutical companies worldwide, including in North America, Europe, and Asia Pacific. With a focus on high-quality products and ongoing innovation, Repligen is well-positioned to capitalize on the growing demand for biologics, driven by advancements in therapeutics and increased investment in the biopharmaceutical sector.